Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Torres-Miñana
Observed names:
L Torres-Miñana,
L. Torres Miñana,
L. Torres-Miñana,
Laura Torres,
Laura Torres Miñana,
Laura Torres‐Miñana
show all 6
Institutions:
Hospital Universitari i Politècnic La Fe,
Centro de Investigación Biomédica en Red de Cáncer,
Instituto de Investigación Sanitaria La Fe
Observed institutions:
Hospital Universitario Insular de Gran Canaria,
Instituto de Salud Carlos III,
Hospital Universitari i Politècnic La Fe,
Hospital Universitario de Gran Canaria Doctor Negrín,
Centro de Investigación Biomédica en Red de Cáncer,
Instituto de Investigación Sanitaria La Fe
show all 6
ORCID:
0009-0005-6930-8059
Observed ORCID:
0009-0005-6930-8059
OpenAlex ID:
A5026905294
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
2024
·
Naval G Daver
, Pau Montesinos
, et al.
·
The Lancet Oncology
·
89
PDF
Management of acquired hemophilia A: results from the Spanish registry
2021
·
María-Eva Mingot-Castellano
, Josep Pardos-Gea
, et al.
·
Blood Advances
·
51
PDF
CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation
2017
·
L Iglesias
, M M Perera
, et al.
·
Bone Marrow Transplantation
·
24
PDF
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia
2023
·
Blanca Boluda
, Antonio Solana-Altabella
, et al.
·
Cancers
·
19
PDF
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
2021
·
María P. Martínez Sánchez
, Juan Eduardo Megías-Vericat
, et al.
·
Annals of Hematology
·
17
S132: Updated Results of Ven-a-qui Study: a Phase 1-2 Trial to Assess the Safety and Efficacy of Triplets for Newly Diagnosed Unfit Aml Patients: Azacitidine or Low-dose Cytarabine With Venetoclax and Quizartinib
2023
·
Juan Miguel Bergua Burgues
, Rebeca Rodríguez-Veiga
, et al.
·
HemaSphere
·
7
Colony-stimulating factor-3 receptor, watch out for polymorphisms
2015
·
C Bilbao-Sieyro
, G Santana
, et al.
·
Leukemia
·
7
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4
2022
·
Sabine Kayser
, David Martínez-Cuadrón
, et al.
·
Haematologica
·
6
PDF
ALL-774: Safety and Efficacy of AZD0486 in Adolescent and Adult Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Early Results From the Phase 1/2 SYRUS Study
2025
·
Ibrahim Aldoss
, Jae-Ho Yoon
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
4
A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study
2025
·
Rebeca Rodríguez-Veiga
, Cristina Gil
, et al.
·
Haematologica
·
3
PDF
P512: Preliminary Results of Ven-a-qui Study: a Phase 1-2 Trial to Assess the Safety and Efficacy of the Combination of Azacitidine or Low-dose Cytarabine With Venetoclax and Quizartinib in Newly Diagnosed
2022
·
J. M. Bergua-Burgues
, R. Rodríguez-Veiga
, et al.
·
HemaSphere
·
3
Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
2022
·
Antonio Solana-Altabella
, Juan Eduardo Megías-Vericat
, et al.
·
Cancers
·
3
PDF
Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia
2026
·
Beatriz Martín‐Herreros
, Lourdes Cordón
, et al.
·
Cytometry Part B Clinical Cytometry
·
2
PDF
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia
2025
·
Antonio Solana-Altabella
, Carles Iniesta-Navalón
, et al.
·
European Journal of Clinical Pharmacology
·
2
PDF
Feasible and Rapid Screening of IDH1/2 and FLT3-TKD2 Mutations by High-Resolution Melting for Patients with Acute Myeloid Leukemia
2025
·
José Vicente Gil
, Sandra de las Heras
, et al.
·
Diagnostics
·
2
PDF
Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain
2025
·
Maria Eva Mingot
, Jose Pardos Gea
, et al.
·
Blood
·
1
PDF
Infectious complications in acquired haemophilia A: Insights from the Spanish Registry (AHASR)
2025
·
Maria-Eva Mingot-Castellano
, Jose Pardos-Gea
, et al.
·
Haematologica
·
1
PDF
Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia
2025
·
Laura Torres-Miñana
, Blanca Boluda
, et al.
·
Cancers
·
1
PDF
Poster: AML-389 Phase 1/2 Study of SEL24/MEN1703, a First-in-Class Dual PIM/FLT3 Kinase Inhibitor, in Patients With IDH1/2-Mutated Acute Myeloid Leukemia: The DIAMOND-01 Trial
2022
·
Giovanni Martinelli
, Armando Santoro
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Temporal Trends in Real‐World Outcomes With CPX‐351 in Secondary/High‐Risk Acute Myeloid Leukemia: A PETHEMA Study
2026
·
Josefina Serrano
, Alicia Aguirre
, et al.
·
Hematological Oncology
PDF
A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Acute Myeloid Leukemia with Isocitrate Dehydrogenase Mutations
2026
·
Pau Montesinos
, Montserrat Arnan Sangerman
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CD84 Expression Across Disease Stages and Leukemic Subpopulations in Acute Myeloid Leukemia
2026
·
Beatriz Martín-Herreros
, Lourdes Cordón
, et al.
·
Cancers
Quizartinib in Combination With FLAG ‐ IDA for Relapsed or Refractory Acute Myeloid Leukemia ( FLAG ‐ QUIDA ): A PETHEMA Phase I‐ II Trial
2026
·
Teresa Bernal
, Javier Zambrano Márquez
, et al.
·
American Journal of Hematology
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group
2026
·
Rafael Colmenares
, Eva Barragán
, et al.
·
Bone Marrow Transplantation
Prognosis of FLT3 ligand level in newly diagnosed FLT3-ITD negative Acute Myeloid Leukemia patients enrolled in the pethema QUIWI trial
2025
·
Antonio Solana-Altabella
, Antonio Moscardó
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
31
Citation count:
243
H-index:
7
I10-index:
5
Year
Topic
Type